Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237467 · ClinicalTrials.gov registry record
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 16
- Enrollment target
NCT04237467: Completed study, sponsored by University of Colorado, Denver.
NCT04237467 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04237467 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in older versus younger transgender men (people who were assigned female at birth but whose gender identity is male). Data will also be compared to those from age group-matched transgender women and cisgender women and men.
Primary Outcome
Brachial artery flow-mediated dilation (FMD), as measured by ultrasound.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-01-29 |
| Est. Completion | 2023-12-31 |
What the finished NCT04237467 record still lists
NCT04237467 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04237467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04237467 about?
NCT04237467 is a clinical study titled "Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men". This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in older versus younger transgender men (people who were assigned female at birth but whose gender identity is male). Data will also be compared to those from age group-matched transgender women...
What is the current status of trial NCT04237467?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2020-01-29. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04237467?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04237467?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI